Literature DB >> 20231500

Gene expression patterns of normal human skin, actinic keratosis, and squamous cell carcinoma: a spectrum of disease progression.

R Steven Padilla1, Sheldon Sebastian, Zeyu Jiang, Ingo Nindl, Richard Larson.   

Abstract

OBJECTIVES: To identify and compare the gene expression profiles of actinic keratosis (AK) and squamous cell carcinoma (SCC) and to further clarify critical genetic alterations in the evolution of SCC from normal sun-damaged human skin.
DESIGN: Observational study.
SETTING: University practice. PATIENTS: Skin biopsy specimens were obtained from 16 patients. The specimens included 14 normal non-sun-exposed skin samples, 14 normal sun-exposed skin samples, 5 AKs, and 15 cutaneous SCCs. MAIN OUTCOME MEASURES: Gene expression profiles from normal non-sun-exposed skin, normal sun-exposed skin, AKs, and SCCs.
RESULTS: Using a highly astringent shrunken centroid threshold of 6.52 and the prediction analysis of microarrays, we identified 89 unique genes that most likely contribute to the molecular evolution of SCC. Our model was cross-validated using data from a separate study and clearly distinguishes between skin tumors (AK and SCC) and normal skin independent of sun exposure. Genes that were upregulated in AK and SCC were downregulated in normal skin, and genes that were downregulated in AK and SCC were upregulated in normal skin.
CONCLUSIONS: The finding of similar differentially expressed genes in AK and SCC confirms that AK is a precursor lesion of SCC and indicates that they are closely related genetically. Clear elucidation of these relationships will be critical to improving therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20231500     DOI: 10.1001/archdermatol.2009.378

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  36 in total

1.  Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2016 MauiDerm Meeting based on presentations by.

Authors:  George Martin; Bruce E Strober; Craig L Leonardi; Joel M Gelfand; Andrew Blauvelt; Arthur Kavanaugh; Linda Stein Gold; Brian Berman; Ted Rosen; Eggert Stockfleth
Journal:  J Clin Aesthet Dermatol       Date:  2016-09-01

2.  Pharmacoeconomy of drugs used in the treatment of actinic keratoses.

Authors:  S Nisticò; V Torchia; M Gliozzi; U Bottoni; E Del Duca; C Muscoli
Journal:  Int J Immunopathol Pharmacol       Date:  2016-05-11       Impact factor: 3.219

3.  Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2017 MauiDerm Meeting.

Authors:  Jo Ann LeQuang
Journal:  J Clin Aesthet Dermatol       Date:  2017-09-01

Review 4.  Actinic keratosis: update on field therapy.

Authors:  Gary Goldenberg; Marcel Perl
Journal:  J Clin Aesthet Dermatol       Date:  2014-10

5.  An update on nonmelanoma skin cancer.

Authors:  Rita V Patel; Amylynne Frankel; Gary Goldenberg
Journal:  J Clin Aesthet Dermatol       Date:  2011-02

Review 6.  Pharmacoeconomic Considerations in Treating Actinic Keratosis: An Update.

Authors:  Spencer M Vale; Dane Hill; Steven R Feldman
Journal:  Pharmacoeconomics       Date:  2017-02       Impact factor: 4.981

7.  An Investigator-initiated Study to Assess the Safety and Efficacy of Imiquimod 3.75% Cream When Used After Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses on Dorsal Hands and Forearms.

Authors:  Gary Goldenberg; Rita V Linkner; Giselle Singer; Amylynne Frankel
Journal:  J Clin Aesthet Dermatol       Date:  2013-02

8.  An Investigator-initiated Study to Assess the Safety and Efficacy of Ingenol Mebutate 0.05% Gel When Used After Cryosurgery in the Treatment of Hypertrophic Actinic Keratosis on Dorsal Hands.

Authors:  Peter W Hashim; John K Nia; Skylar Singer; Gary Goldenberg
Journal:  J Clin Aesthet Dermatol       Date:  2016-07-01

Review 9.  How to treat actinic keratosis? An update.

Authors:  Claudia Costa; Massimiliano Scalvenzi; Fabio Ayala; Gabriella Fabbrocini; Giuseppe Monfrecola
Journal:  J Dermatol Case Rep       Date:  2015-06-30

10.  Defining Field Cancerization of the Skin Using Noninvasive Optical Coherence Tomography Imaging to Detect and Monitor Actinic Keratosis in Ingenol Mebutate 0.015%- Treated Patients.

Authors:  Orit Markowitz; Michelle Schwartz; Eleanor Feldman; Amy Bieber; Amanda Bienenfeld; Naveen Nandanan; Daniel M Siegel
Journal:  J Clin Aesthet Dermatol       Date:  2016-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.